Full Webinar: Patient Burden in Clinical Trials: Ethics of Biospecimen Management

When protocol deviations occur, who bears the brunt? Often, it's the patient.
In this insightful discussion, TruLab’s expert panelists delve into the clinical trial patient experience and the ethical considerations that accompany biospecimen management.
Clinical trial participant Joel Vanderbrink shares the challenges he faced during a study for Crohn’s Disease, including the significant burden he experienced following protocol deviations that resulted in lost samples.
Clinical research veterans Dr. Julius Wilder, a principal investigator and associate professor at Duke University’s School of Medicine, and TruLab’s Vice President of Client Services Jim Wahl further explore this issue, discussing the ethical implications of sample mishandling and the importance of patient-centric trial design and execution. They also address common concerns such as the length of informed consent documents and the necessity of comprehensive participant support.
Key topics include:
👉Reducing patient burden through streamlined protocols
👉Integrating mental health and other supports for clinical trial patients
👉Improving post-trial engagement and feedback for participants
Join us for an engaging conversation that sheds light on the evolving landscape of clinical research and the steps needed to prioritize patient well-being.
🔔 Subscribe for more insights on streamlining clinical trials.